(22) observed that those with a KCNJ5 mutation taking fewer anti hypertensives and with shorter duration of HTN had complete resolution of HTN with significant improvement in their LV hypertrophy when compared to the wild type. This evidence concerns the gene KCNJ5 and hypertensive disorder.